The study by Sari Reisner and colleagues1 in The Lancet HIV on gender-affirming hormone therapy and its effect on HIV ...

With the 24% cuts and PEPFAR discontinued, we estimated there could be 4.43 million to 10.75 million additional HIV ...

The majority of men also admit to never having tested for HIV, despite over a third (37%) having regular unprotected sex. Of those surveyed, 34% believe they are unlikely ever to contract HIV, and 20% ...

Early HIV detection can mean the difference between a long, healthy life and severe complications. Learn why timing matters ...

A recent study published in The Lancet HIV, conducted by the Burnet Institute and WHO, showed a critical issue regarding ...

The target of ending the global TB epidemic by 2035 is achievable, Cimas Health Group doctor Philip Manema believes, if there ...

Transgender people receiving gender-affirming hormone therapy have a 37% lower chance of acquiring HIV, and for people living with HIV, hormone therapy appears to offer a 44% lower chance of the virus ...

Researchers show that the immune system can recognize and control the latent stage of the parasite Toxoplasma gondii, a finding that can inform the study of latency in other infections of the nervous ...

Sudan has been engulfed in a devastating war that has crippled its health system and displaced millions. The conflict that erupted in April, 2023, between the Sudanese Armed Forces and the ...

A study published in Lancet HIV Thursday showed that patients who received gender-affirming hormones were 37% less likely to ...

A new study published in The Lancet HIV warns that proposed cuts to foreign aid by major donor countries could wipe out ...

When much of the world was first introduced to physical distancing when COVID broke out in 2020, gay San Francisco resident ...